These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32219144)

  • 1. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells.
    Yuan P; Zhou Y; Wang R; Chen S; Wang Q; Xu Z; Liu Y; Yang H
    Biomed Res Int; 2020; 2020():8450606. PubMed ID: 32219144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite Motif Containing 11 Interacts with DUSP6 to Promote the Growth of Human Osteosarcoma Cells through Regulating ERK1/2 Pathway.
    Wang Z; Xu X; Tang W; Zhu Y; Hu J; Zhang X
    Biomed Res Int; 2019; 2019():9612125. PubMed ID: 31950060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
    Wang J; Fang Y; Liu T
    Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
    Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
    World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
    Liu ZX; Hong L; Fang SQ; Tan GH; Huang PG; Zeng Z; Xia X; Wang XX
    Tumour Biol; 2016 Nov; 37(11):14923-14928. PubMed ID: 27644251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.
    Shang R; Chen J; Gao Y; Chen J; Han G
    Dis Markers; 2023; 2023():5899662. PubMed ID: 36644609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect.
    Wu H; Guo X; Jiao Y; Wu Z; Lv Q
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36196894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis.
    Pu F; Liu J; Jing D; Chen F; Huang X; Shi D; Wu W; Lin H; Zhao L; Zhang Z; Lv X; Wang B; Zhang Z; Shao Z
    Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
    Jiang W; Cai X; Xu T; Liu K; Yang D; Fan L; Li G; Yu X
    Oncol Res; 2020 Sep; 28(4):409-421. PubMed ID: 32295675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Liu M; Zhang X; Cai J; Li Y; Luo Q; Wu H; Yang Z; Wang L; Chen D
    Oncol Rep; 2018 Sep; 40(3):1251-1260. PubMed ID: 29956813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of PKM2 Gene Silencing on the Proliferation and Apoptosis of Colorectal Cancer LS-147T and SW620 Cells.
    Ao R; Guan L; Wang Y; Wang JN
    Cell Physiol Biochem; 2017; 42(5):1769-1778. PubMed ID: 28746922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D; Yang J; Ma H; Sun C; Feng R
    J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
    Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
    Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
    Yan XL; Zhang XB; Ao R; Guan L
    J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
    Qiu X; Huang Y; Zhou Y; Zheng F
    Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.